<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGas</journal-id><journal-title-group><journal-title>Open Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2163-9450</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgas.2020.101003</article-id><article-id pub-id-type="publisher-id">OJGas-97679</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Evolutionary and Pronostic Aspects of Cirrhosis at the University Hospital of Brazzaville (Congo)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jile</surname><given-names>Florient Mimiesse</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ngalessami</surname><given-names>Mouakosso Marlyse</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ahoui</surname><given-names>Apendi Clausina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Atipo-Ibara</surname><given-names>Ollandzobo Lucie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Firmin</surname><given-names>Bossali</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Akoa</surname><given-names>Ngala Itoua-Ngaporo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rody</surname><given-names>Stéphane Ngami</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Deby</surname><given-names>Gassaye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Atipo</surname><given-names>Ibara Blaise Irénée</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ibara</surname><given-names>Jean-Rosaire</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mongo</surname><given-names>Onkouo Arnaud</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mahoungou</surname><given-names>Gael Honal</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Congo</addr-line></aff><aff id="aff2"><addr-line>Gastroenterology Service, University Hospital of Brazzaville, Brazzaville, Congo</addr-line></aff><pub-date pub-type="epub"><day>27</day><month>12</month><year>2019</year></pub-date><volume>10</volume><issue>01</issue><fpage>23</fpage><lpage>29</lpage><history><date date-type="received"><day>26,</day>	<month>August</month>	<year>2019</year></date><date date-type="rev-recd"><day>5,</day>	<month>January</month>	<year>2020</year>	</date><date date-type="accepted"><day>8,</day>	<month>January</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Introduction:</b> cirrhosis is a serious pathology that leads to complications whose management remains difficult in our country. This study aimed to evaluate the evolutionary aspects of cirrhosis at the Brazzaville University Hospital. 
  <b>Patients and methods: </b> this was a retrospective study over a period of 18 months (from January 2015 to July 2016), performed in the Gastroenterology Department of the Brazzaville University Hospital. All patients regularly followed for decompensated cirrhosis were included. The studied variables were the epidemiological, clinical and paraclinical characteristics, the occurrence of complications, the survival, and the causes of death. Univariate analysis was used to determine prognostic factors based on the Child Pugh score. 
  <b>Results: </b> There were 43 patients, including 32 men and 11 women, with a mean age of 52 &#177; 9.5 years. Viral hepatitis B was the most common etiology (39.5%). Child Pugh stage C was found in 60.5%. Oesophageal varices were present in 93% of cases. Survival at 18 months was 72%. In univariate analysis, two variables were significantly associated with decreased survival, including Child Pugh stage C and esophageal varices (grade II and III). 
  <b>Conclusion:</b> cirrhosis remains a worrying pathology because the diagnosis is often made at the stage of often serious complications putting at risk of vital prognosis.
 
</p></abstract><kwd-group><kwd>Cirrhosis</kwd><kwd> Evolution</kwd><kwd> Brazzaville</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cirrhosis is the ultimate stage of evolution of chronic liver disease. It is a serious pathology whose evolution is peppered with complications that evolve towards death [<xref ref-type="bibr" rid="scirp.97679-ref1">1</xref>]. Early diagnosis involves the means of investigation, the most recent of which are the non-invasive tests for fibrosis [<xref ref-type="bibr" rid="scirp.97679-ref2">2</xref>]. The lifespan of patients with cirrhosis is influenced by etiological, sociodemographic factors, the stage of development at the time of diagnosis and the level of the technical plateau [<xref ref-type="bibr" rid="scirp.97679-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.97679-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.97679-ref5">5</xref>].</p><p>The management of cirrhosis and its complications is difficult in Congo, where the means of early diagnosis and specific therapeutic means are not available [<xref ref-type="bibr" rid="scirp.97679-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.97679-ref5">5</xref>].</p><p>In order to improve the management of cirrhosis and its complications, we conducted this study whose main objective was to evaluate the evolutionary aspects of cirrhosis.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This was a retrospective study from January 2015 to July 2016, for a period of 18 months. The study took place in the Department of Gastroenterology and Internal Medicine (GEMI) of the Brazzaville University and Hospital Center. We included patients whose discharge diagnosis was decompensated cirrhosis and who received regular follow-up after discharge. The diagnosis was made in the presence of signs of hepatocellular insufficiency, signs of portal hypertension and liver characteristics. Hepatic biopsy (PBH) was not performed due to lack of material for transjugular PBH and all patients were seen at the decompensation stage preventing transparietal PBH. Patients who died during hospitalization, who were released against medical advice or were lost to follow-up, were not included in the study. After discharge, all patients were reviewed one week later, then every two weeks, and once a month, depending on the outcome. The study variables were: socio-demographic (age, sex, occupation), reason for hospitalization, etiology of cirrhosis, Child Pugh stage, complications during follow-up, patient outcome, circumstances death, survival time and correlations between death and the variables studied. The size of our sample was evaluated by the Shwartz formula.</p><p>All data were collected on a survey sheet and analyzed on epi-info version 6.0). The Chi-square test was used to compare our results that were significant for a probability p &lt; 0.05. The survival curve was made according to the Kaplan Meier Method.</p></sec><sec id="s3"><title>3. Results</title><p>During the study period, 2312 patients were hospitalized in the GEMI department of the University Hospital of Brazzaville, including 203 cases (8.7%) of cirrhosis. Forty-three cases meeting our inclusion criteria were selected.</p><p>Men accounted for 74.4% of cases (n = 32) and women for 25.6% of cases (n = 11). The sex ratio of 2.9. The average age was 52 &#177; 9.5 years with extremes ranging from 21 to 79 years. The most represented age group was 40 to 59 years old.</p><p>The average consultation time was 4 weeks with extremes ranging from less than a week to three months.</p><p>The most common clinical signs were ascitic and edema of the lower limbs (see <xref ref-type="table" rid="table1">Table 1</xref>).</p><p>In our study 60.5% of patients were classified as Child Pugh C, 30.9% were Child Pugh B and 9.2 were Child Pugh A.</p><p>Oesophageal varices were found in 93% of patients (n = 40) and HTP gastropathy in 25.6% of patients (n = 11).</p><p>In 65% of the cases (n = 37) cirrhosis was viral in origin, related to B virus in 39.5% of cases. The concept of oenolism was found in 20.9% of patients, 9.3% of whom were associated with the hepatitis B virus.</p><p>Regarding evolutionary data, the overall duration of follow-up was 18 months with extremes ranging from 6 to 18 months. The main complication during follow-up was refractory ascites (see <xref ref-type="table" rid="table2">Table 2</xref>).</p><p>In our study, overall survival was 72% according to the Kaplan Meier method (see <xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>The main causes of death were hepatic encephalopathy in 36.4% of cases (n = 4), gastrointestinal bleeding in 27.3% of cases (n = 3), hepatorenal syndrome in 18.1% of cases (n = 2), ascites fluid infection and hepatocellular carcinoma in 9.1% (n = 1) respectively.</p><p>In univariate analysis mortality was significantly related to the Child Pugh stage (p = 0.0088) and to the presence of large oesophageal varices (p = 0.01) (see <xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of patients by clinical signs</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Clinical signs</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Ascites</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >83.7</td></tr><tr><td align="center" valign="middle" >Edema of the lower limbs</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >72.1</td></tr><tr><td align="center" valign="middle" >Hepatomegaly</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >32.6</td></tr><tr><td align="center" valign="middle" >Splenomegaly</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >27.9</td></tr><tr><td align="center" valign="middle" >Icterus</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >25.6</td></tr><tr><td align="center" valign="middle" >Circulation veineuse collat&#233;rale</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >18.6</td></tr><tr><td align="center" valign="middle" >Digital Hippocratism</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >18.6</td></tr><tr><td align="center" valign="middle" >Hepatic encephalopathy</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >16.3</td></tr><tr><td align="center" valign="middle" >Pleurisy</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >14</td></tr><tr><td align="center" valign="middle" >Melena</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Signs of alcoholism</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4.7</td></tr><tr><td align="center" valign="middle" >Hematemesis</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4.7</td></tr><tr><td align="center" valign="middle" >Gynecomastia</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.3</td></tr><tr><td align="center" valign="middle" >Fetor hepatis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.3</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of patients by complications during follow-up</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >6 months n = 43</th><th align="center" valign="middle" >12 months n = 43</th><th align="center" valign="middle" >18 months n = 43</th></tr></thead><tr><td align="center" valign="middle" >Ascites fluid infection</td><td align="center" valign="middle" >6 (13.9%)</td><td align="center" valign="middle" >4 (9.3%)</td><td align="center" valign="middle" >3 (7%)</td></tr><tr><td align="center" valign="middle" >Gastrointestinal bleeding</td><td align="center" valign="middle" >6 (13.9%)</td><td align="center" valign="middle" >5 (11.6%)</td><td align="center" valign="middle" >4 (9.3%)</td></tr><tr><td align="center" valign="middle" >Hepatic encephalopathy</td><td align="center" valign="middle" >5 (11.6%)</td><td align="center" valign="middle" >6 (13.9%)</td><td align="center" valign="middle" >8 (18.6%)</td></tr><tr><td align="center" valign="middle" >Hepatocellular carcinoma</td><td align="center" valign="middle" >1 (2.3%)</td><td align="center" valign="middle" >2 (4.6%)</td><td align="center" valign="middle" >3 (7%)</td></tr><tr><td align="center" valign="middle" >Hepatorenal syndrome</td><td align="center" valign="middle" >1 (2.3%)</td><td align="center" valign="middle" >3 (7%)</td><td align="center" valign="middle" >3 (7%)</td></tr><tr><td align="center" valign="middle" >Ascites or his aggravation</td><td align="center" valign="middle" >22 (51.1%)</td><td align="center" valign="middle" >18 (41.9%)</td><td align="center" valign="middle" >27 (62.8%)</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Univariate analysis of death-related factors</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Living</th><th align="center" valign="middle" >deceased</th><th align="center" valign="middle" >Total</th></tr></thead><tr><td align="center" valign="middle" >Child Pugh Score</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >A</td><td align="center" valign="middle" >4 (100%)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >B</td><td align="center" valign="middle" >13 (100%)</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >13</td></tr><tr><td align="center" valign="middle" >C</td><td align="center" valign="middle" >15 (57.7%)</td><td align="center" valign="middle" >11 (42.3%)</td><td align="center" valign="middle" >26</td></tr><tr><td align="center" valign="middle"  colspan="4"  >p = 0.008</td></tr><tr><td align="center" valign="middle" >Gradeoesophageal varices</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Oesophageal varices I</td><td align="center" valign="middle" >3 (100%)</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >3 (100%)</td></tr><tr><td align="center" valign="middle" >Oesophageal varices II</td><td align="center" valign="middle" >16 (94.1%)</td><td align="center" valign="middle" >1(5.9%)</td><td align="center" valign="middle" >17 (100)</td></tr><tr><td align="center" valign="middle" >Oesophageal varices III</td><td align="center" valign="middle" >11 (55%)</td><td align="center" valign="middle" >9 (45%)</td><td align="center" valign="middle" >20 (100%)</td></tr><tr><td align="center" valign="middle"  colspan="4"  >p = 0.01</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>Our study is limited by the mono-centric character and the small size of the sample limits us in the extrapolation of our results.</p><p>In the Congo, cirrhosis is most often diagnosed in relatively young male subjects. These results are consistent with data published by several African authors [<xref ref-type="bibr" rid="scirp.97679-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.97679-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.97679-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.97679-ref9">9</xref>], because of the young age of the general population, but also because of the high prevalence of chronic carriage of hepatitis virus B.</p><p>The oedemato-ascitic syndrome was one of the main reasons for hospitalization in our study. This finding is similar to that reported by Yao Bataix and Diarra [<xref ref-type="bibr" rid="scirp.97679-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.97679-ref10">10</xref>]. The oedematous-ascitic syndrome has been described by Pariente [<xref ref-type="bibr" rid="scirp.97679-ref11">11</xref>] as a frequently revealing complication of the disease.</p><p>The delay in consultation found in almost 50% of cases is probably related to our cultural context where patients first resort to churches and traditional healers in case of illness, before going to the hospital in the absence of improvement.</p><p>The delay in the consultation probably explains in part the advanced stage of the Child-Pugh stage C in more than half of the patients. This is close to the results of Bossali in Pointe-Noire in Congo [<xref ref-type="bibr" rid="scirp.97679-ref5">5</xref>]. However, in the studies of Yao Bataix and Karoui [<xref ref-type="bibr" rid="scirp.97679-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.97679-ref12">12</xref>], the stage at diagnosis is relatively less advanced, mainly stage B of Child Pugh.</p><p>Oesophageal varices are the most frequently found endoscopic signs, but the endoscopic stage is variously appreciated by the authors. In our work there is a high frequency of esophageal varices stage III, which corroborates the work of Diarra in Mali [<xref ref-type="bibr" rid="scirp.97679-ref10">10</xref>] and Moulion Tapouh in Cameroon [<xref ref-type="bibr" rid="scirp.97679-ref13">13</xref>] with respective frequencies of 67.23% and 82.4% of cases. On the other hand Yao Bathaix et al. [<xref ref-type="bibr" rid="scirp.97679-ref7">7</xref>] found a predominance for oesophageal varices stage II (51.32%). All of these studies confirm the advanced stage of diagnosis in African countries. In Caucasian series, however, the frequency of stage 3 varices is generally less than 30% [<xref ref-type="bibr" rid="scirp.97679-ref3">3</xref>].</p><p>Viral hepatitis is the most common cause of cirrhosis in our study with a predominance of hepatitis B. These results are similar to those of Sehonou in Benin [<xref ref-type="bibr" rid="scirp.97679-ref14">14</xref>] and Yao Bathaix in C&#244;te d'Ivoire [<xref ref-type="bibr" rid="scirp.97679-ref7">7</xref>] who recovered hepatitis B respectively in 30.8% and 76.04% of cases.</p><p>Ascites was the main complication found during follow-up. This finding is clearly superior to that reported by Pariente [<xref ref-type="bibr" rid="scirp.97679-ref11">11</xref>], which found less than 50% of cases. This frequency could be explained in our patients by the poor therapeutic observance, the absence of therapeutic alternative in case of refractory ascites and especially the high cost of complementary examinations during the follow-up [<xref ref-type="bibr" rid="scirp.97679-ref6">6</xref>].</p><p>The global mortality is variously appreciated by the authors certainly because of the mode of recruitment of the patients. Our study found 25.58% during the survival period, Bossali in Pointe Noire [<xref ref-type="bibr" rid="scirp.97679-ref5">5</xref>] found 68.2% and Diarra in Mali [<xref ref-type="bibr" rid="scirp.97679-ref10">10</xref>] 82.5%.</p><p>The low mortality rate observed in our study is probably biased by the small sample size and the short duration of follow-up.</p><p>The circumstances of death were mainly hepatic encephalopathy, gastrointestinal bleeding and hepatorenal syndrome. This is related to the advanced stage of the disease and the difficulties of management related to the insufficiency of the technical platform.</p><p>The mortality is significantly correlated with the Child Pugh score and the oesophageal varices stage. In our study, Child Pugh stage C and grade III oesophageal varices were significantly correlated with high mortality (p = 0.08, p = 0.01). Our results corroborate those of Ren&#233; Robert [<xref ref-type="bibr" rid="scirp.97679-ref15">15</xref>].</p><p>Bossali et al. [<xref ref-type="bibr" rid="scirp.97679-ref5">5</xref>] found a high mortality for Child Pugh stage C (p = 0.00034) and the existence of complications upon admission (p = 0.0001). Similarly for Diarra et al. [<xref ref-type="bibr" rid="scirp.97679-ref10">10</xref>], the mortality is significantly high when the patients had a Child Pugh stage C score with 63.3% (p = 0.008).</p></sec><sec id="s5"><title>5. Conclusion</title><p>Cirrhosis remains a serious condition because the diagnosis is often made at the stage of serious complications that are life-threatening. Ascites was the main reason for consultation and hospitalization. The main causes of death identified were hepatic encephalopathy and gastrointestinal bleeding. Factors associated with mortality were Child Pugh stage C and oesophageal varices III.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Mimiesse, J.F., Marlyse, N.M., Clausina, A.A., Arnaud, M.O., Lucie, A.-I.O., Bossali, F., Itoua-Ngaporo, A.N., Ngami, R.S., Honal, M.G., Gassaye, D., Ir&#233;n&#233;e, A.I.B. and Jean-Rosaire, I. (2020) Evolutionary and Pronostic Aspects of Cirrhosis at the University Hospital of Brazzaville (Congo). Open Journal of Gastroenterology, 10, 23-29. https://doi.org/10.4236/ojgas.2020.101003</p></sec></body><back><ref-list><title>References</title><ref id="scirp.97679-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Benhamou, J.P. and Erlinger, S. (2000) Maladie du foie et des voies biliaires. Flammarion, Paris, 223 p.</mixed-citation></ref><ref id="scirp.97679-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Voitot, H. (2006) Biologie et cirrhose. Revue Francophone des Laboratoires, 387, 65-71. https://doi.org/10.1016/S1773-035X(06)80500-9</mixed-citation></ref><ref id="scirp.97679-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Younsi</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>Histoire naturelle de la cirrhose du foie: Indicateur pronostiques et complications</article-title><source> Espérance Médicale</source><volume> 13</volume>,<fpage> 375</fpage>-<lpage>378</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.97679-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ibara, J.-R., Ossendza, R.A., Okouo, M., et al. (1999) Les cancers primitifs du foie au Congo: étude hospitalière de 558 cas. Médecine d’Afrique Noire, 46, 394-397.</mixed-citation></ref><ref id="scirp.97679-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Bossali, F., Deby, G., Atipo, B.I., et al. (2015) Evaluation de la performance des services d’hépatogastroentérologie pour la prise en charge des cirrhoses au Congo-Brazzaville en 2014. Journal Africain d’Hépato-Gastroentérologie, 9, 58-59. https://doi.org/10.1007/s12157-015-0593-9</mixed-citation></ref><ref id="scirp.97679-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Atipo-Ibara</surname><given-names> B.I.</given-names></name>,<name name-style="western"><surname> Ondele-Ngoli</surname><given-names> A.</given-names></name>,<name name-style="western"><surname> Deby-Gassaye</surname><given-names> et al. </given-names></name>,<etal>et al</etal>. (<year>2004</year>)<article-title>Le co&amp;ucirc;t financier de la prise en charge hospitalière de la cirrhose et de ses complications au CHU de Brazzaville</article-title><source> Médecine Tropicale</source><volume> 64</volume>,<fpage> 50</fpage>-<lpage>52</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.97679-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Yao Bathaix, M.F., Bagny, A., Mahassadi, K.A., et al. (2015) Prognostic Factors for Cirrhosis Hospital in Abidjan (C&amp;ocirc;te d’Ivoire). Journal of Gastroenterology, 5, 103-109. https://doi.org/10.4236/ojgas.2015.57017</mixed-citation></ref><ref id="scirp.97679-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Attia, A.K., N’Dri-Yoman, T., Sawadogo, A., et al. (2001) L’infection spontanée du liquide d’ascite chez le cirrhotique africain. Etude descriptive à propos de 12 cas. Bulletin de la Société de Pathologie Exotique, 94, 319-321.</mixed-citation></ref><ref id="scirp.97679-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ndububa, D.A., Ojo, O.S., Adeodu, O.O., Adetiloye, V.A., et al. (2001) Primary Hepatocellular Carcinoma in Ile-Ife, Nigeria: A Prospective Study of 154 Cases. Nigerian Journal of Medicine, 10, 59-63.</mixed-citation></ref><ref id="scirp.97679-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Diarra, M., Konaté, A., Soukho, A., Epouse, K., et al. (2010) Aspects évolutifs de la maladie cirrhotiques dans un service d’hépatogastroentérologie au Mali. Mali Médical, 1, 42-46.</mixed-citation></ref><ref id="scirp.97679-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Pariente, A. (2006) Décompensation ascitique. Gastroentérologie Clinique et Biologique, 30, 870-874. https://doi.org/10.1016/S0399-8320(06)73334-6</mixed-citation></ref><ref id="scirp.97679-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Karoui, S., Hamzaoui, S., Sahli, F., et al. (2002) Mortalité au cours de la cirrhose: Prévalence, causes et facteurs prédictifs. La Tunisie Médicale, 80, 21-25.</mixed-citation></ref><ref id="scirp.97679-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Moulion Tapouh, J.R., Njoya, O., Monabang Zoé, C., et al. (2015) Approche non endoscopique du diagnostic des varices &amp;oelig;sophagiennes d’origine cirrhotique dans une population d’Afrique noire subsaharienne. Health Sciences and Diseases, 16, 1-5.</mixed-citation></ref><ref id="scirp.97679-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sehonou, J., Kodjoh, N., Sake, K.L., et al. (2010) Cirrhose hépatique à Cotonou (République du Bénin): Aspects cliniques et facteurs liés au décès. Médecine Tropicale, 70, 375-378.</mixed-citation></ref><ref id="scirp.97679-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Robert, R. and Nanadoumgar, H. (2005) Pronostic du malade cirrhotique en réanimation. Hépato-Gastro, 12, 413-418.</mixed-citation></ref></ref-list></back></article>